146
E. Beneventi et al. / Journal of Molecular Catalysis B: Enzymatic 98 (2013) 145–154
equivalents allowing molecular oxygen binding. Depending on
cofactor usage, BVMOs can be classified into two types [13].
Type I BVMOs are FAD and NADPH dependent and contain two-
dinucleotide binding domains (␣-folds) known as Rossman
motifs, one for the FAD binding and the other one for the NADPH
binding. They are composed of only one polypeptide. Type II BVMOs
are FMN and NADH dependent and consist of two distinct subunits,
a dehydrogenase using NADH to reduce FMN and a second sub-
unit able to perform the Baeyer–Villiger reaction using the reduced
flavin.
FeSO4 7H2O, 500 mg/l NH4 tartrate, 5 g/l glucose, 1 ml KH2PO4/KOH
buffer pH 7, and 1 ml trace solution elements per liter. KH2PO4/KOH
buffer contained 25 g KH2PO4 per 100 ml of milliQ water; pH 7 was
obtained by titrating with 4 M KOH. Trace element solution con-
tained 55 mg/l CuSO4 5H2O, 55 mg/l ZnSO4·7H2O, 614 mg/l H3BO3,
389 mg/l MnCl2·4H2O, 55 mg/l CoCl2·6H2O, 28 mg/l KI, 25 mg/l
Na2MoO4·2H2O. Cultures were grown in a growth chambers at
24 ◦C, with 16 h light/8 h dark photoperiod and a light intensity of
40–50 E. Nutrition media were autoclaved for 20 min at 121 ◦C
and plant agar (7 g/l) was added in order to prepare solid media.
the Baeyer–Villiger reaction, involved in mithramycin biosynthe-
sis. Mithramycin is a polyketide anticancer antibiotic produced
by the soil bacterium Streptomyces argillaceus (ATCC 12956) and
other streptomycetes [14]. Sequence analysis and crystal structure
revealed that MtmVIO can not be classified as a type I or type II
BVMOs but it appears to be an atypical BVMO belonging to a differ-
ent flavoprotein monooxygenase family [15].
The best-characterized BVMOs are those of type I, which display
cyclohexanone monooxygenase (CHMO) from Acinetobacter NCIMB
9871 and phenylacetone monooxygenase (PAMO) from Thermobi-
fida fusca. The former enzyme was also the first one to be described,
in the middle seventies [17]. Up to ten years ago, however, few
BVMOs had been cloned and overexpressed. Thanks to the vast
genetic information that has become available by genome sequenc-
In particular, the technique of genome mining has proved to be
an efficient approach to discover new biocatalysts. Previous stud-
ies performed by this approach showed that type I BVMOs were
present in a vast variety of bacteria and fungi, but no representative
was found in Archea, plants or human genomes [18].
In order to find novel and promising biocatalysts, we used
the genome mining approach to uncover BVMOs within specific
and unusual organisms. Using the sequence of a prototype BVMO,
phenylacetone monooxygenase (PAMO), as template and the “fin-
gerprint” motif for type I BVMOs (FxGxxxHxxxWP/D; [19]) as
discriminant, we have identified two new putative BVMO-encoding
very uncommon sources for BVMOs. In fact, only two BVMOs from
eukaryotic origin have been cloned and expressed to date. Both
BVMOs were derived from fungi: the ascomycetes Cylindrocarpon
radicicola ATCC 11011 [20] and Aspergillus fumigatus Af293 [21]. The
discovery of BVMOs in photosynthetic eukaryotes is novel and may
provide new biocatalytic features.
2.2. Reagents and enzymes
All chemicals were purchased from Fluka and Sigma–Aldrich
(Milan, Italy). Restriction enzymes were obtained from New
England Biolabs (NEB) or from Promega; PhusionTM High-fidelity
DNA polymerase from Finnzymes; TSAP (Thermosensitive Alkaline
Phosphatase) from Promega; T4 DNA Ligase from NEB. IMAC-Select
Affinity Gel resin was purchased from Sigma–Aldrich.
2.3. Sequence analysis and cloning
The NCBI resource was used for DNA sequence analysis; searches
and multiple alignments of BVMO sequences were respectively
produced by programs BLAST and ClustalW.
Expression vectors were produced by digestion of pET-28a(+)
with NcoI/NotI and ligation of the amplified Cm-BVMO and Pp-
BVMO sequences, cut by the same enzymes. These sequences
were obtained by two subsequent PCR reactions, the first one
producing
a preliminary “large” amplimer, which was then
used for the second amplification, by nested mutagenic primers.
The following synthetic oligonucleotides were used for PCR
amplification of the target gene from C. merolae genomic DNA:
external primer pair, forward 5ꢀ-AGTGATGCGCGTGGCCGGCA-3ꢀ
and reverse 5ꢀ-AGGTGTCTGCACCTCGCCAGCG-3ꢀ; nested primer
pair,
forward
5ꢀ-TTTGACCGGCCATGGGAGCGGAGCTCAAC-3ꢀ
and reverse 5ꢀ-GCATCCACCGCGCCGGCGTACAGCGAAG-3ꢀ. The
following synthetic oligonucleotides were used for PCR amplifi-
cation of the target gene from P. patens genomic DNA: external
primer pair, forward 5ꢀ-ACAGGCCACGGGGGTAGTTCTGTTG-
3ꢀ
and
reverse
5ꢀ-CAACCCTGGACAGCATCGGAAGCCT-3ꢀ;
nested primer pair, forward 5ꢀ-AAGTATGTCCAATTCCATGGC-
TGAGTTCGATGCTGTTATAGTCGGAG-3ꢀ and reverse 5ꢀ-AAACAAT-
GCCCGCGGCCGCCAGCTTGAATCCC-3ꢀ. The sequence variant
Y160H was constructed using the QuikChange® II Site-Directed
Mutagenesis Kit of Stratagene using plasmid pET28 Pp-BVMO
as template with the oligonucleotide 5ꢀ-GGCTCATCGTACCA-
CACGGGC-3ꢀ and its complementary one.
2. Experimental
2.4. Expression, analysis and purification of recombinant proteins
2.1. Organisms and culture conditions
The recombinant enzymes, hereafter called Cm-BVMO, Pp-
BVMO and Pp-Y160H-BVMO, were expressed in E. coli BL21 (DE3)
or E. coli ARCTIC Express® (Stratagene). Pre-cultures were carried
out in 5 ml LB medium at 37 ◦C containing 50 g/ml kanamycin.
Larger cultures were carried out in 1 L LB medium with riboflavin
addition (100 M). The cells were grown in a shaking incubator
at 37 ◦C to an optical density at 600 nm (OD600) of 0.4–0.6, then
induced by addition of IPTG to a final concentration of 0.2 mM and
cultivated at 18 ◦C overnight. The cells were harvested by centrifu-
gation (4 ◦C, 10 min, 4500 × g) and washed with Tris/HCl buffer (Tris
50 mM, pH 8.0). Cell disruption was obtained by French Press and
crude extract was centrifuged (4 ◦C, 20 min, 15,000 × g) to separate
soluble e insoluble fractions. FAD cofactor (at 100 M final concen-
tration) was added to the crude extract before cell disruption.
Cyanidioschyzon merolae strain 10D (NIES-1332) was obtained
from the Microbial Culture Collection of the National Institute
for Environmental Studies, Tsukuba, Japan. Cultures of C. merolae
500 ml flasks on a rotatory platform shaker at 70 rpm. Light condi-
tions used were 25–27 mol photons m−2 sec−1
.
E. coli strains (XL1-blue and BL21 (DE3)) were routinely cul-
tured in LB media and supplemented with the antibiotic kanamycin
(50 g/ml).
The starting culture of Physcomitrella patens was kindly pro-
vided by Dr. Tomas Morosinotto (Department of Biology, University
of Padova). It was cultivated by micro propagation in PpNH4 rich
medium: 0.8 g/l CaNO3 4H2O, 0.25 g/l MgSO4 7H2O, 0.0125 g/l